Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

APC

Authors Guide Submit Manuscript

Crossref

1. Response Tailored Protocol Versus the Fixed 12 Weeks Course of Dual Sofosbuvir/Daclatasvir Treatment in Egyptian Patients With Chronic Hepatitis C Genotype-4 Infection: A Randomized, Open-label, Non-inferiority Trial

- Mostafa Yakoot

- Alaa M. Abdo

- Siham Abdel-Rehim

- Sherine Helmy

2. SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial

- Shahin Merat

- Amir-Houshang Sharifi

- Hossein Poustchi

- Eskandar Hajiani

- Abdolsamad Gharavi

- Jalal Karimi

- Fariborz Mansour-Ghanaei

- Mohammad-Reza Fattahi

- Lida Ahmadi

- Mohammad-Hossein Somi

- Hamid Kalantari

- Mohammad-Reza Ghadir

- Farshad Sheikhesmaeili

- Nadieh Baniasadi

- Masoudreza Sohrabi

- Seyedhamid Moosavy

- Masood Ziaee

- Mohammad-Javad Zahedi

- Marjan Mokhtare

- Shahnaz Sali

- Babak Sayad

- Behrooz Afshar

- Alireza Bakhshipour

- Abazar Parsi

- Afsaneh Sharifian

- Taghi Amiriani

- Zeinab Malekzadeh

- Dorsa Merat

- Azita Ganji

- Fereidoun Rahmani-Samani

- Raika Jamali

- Masoomeh Sofian

- Mohammad Ghezlou

- Amir Ali Sohrabpour

- Ladan Goshayeshi

- Seyed-Mohammad Valizadeh-Toosi

- Layli Eslami

- Iradj Maleki

- Ahmad Hormati

- Ali-Akbar Shayesteh

- Elahe Shayesteh

- Alireza Norouzi

- Zahra Abna

- Alireza Janbakhsh

- Hafez Fakheri

- Mohammad Minakari

- Hossein Sardarian

- Adel Fallah Ghajary

- Mojtaba Fattahi-Abdizadeh

- Maryam Latifnia

- Fatemeh Roozbeh

- Shahram Agah

- Saba Fakhrieh-Asl

- Alireza Nateghi-Baygi

- Babak Fattahi

- Helia Nateghi-Baygi

- Andrew Hill

- Reza Malekzadeh

3. Pure component contribution (PCCA) and synergy interval partial least squares (siPLS) algorithms for efficient resolution and quantification of overlapped signals; an application to novel antiviral tablets of daclatasvir, sofosbuvir and ribavirin

- Maha Mahmoud Abou El-Alamin

- Maha Abd Elrahman Sultan

- Maha Hegazy

- Alastair William Wark

- Marwa Mohamed Azab

4. Treatment of Hepatitis C Infection with Direct-Acting Antiviral Agents in Liver-Transplant Patients: A Systematic Review and Meta-Analysis

- Mohammad Saeid Rezaee-Zavareh

- Khashayar Hesamizadeh

- Heidar Sharafi

- Seyed Moayed Alavian

5. Research progress on the direct antiviral drugs for hepatitis C virus

- Jianjun Gao

- Chuanxia Ju

6. High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam

- Didier Laureillard

- Nguyen Thanh Binh

- Vu Hai Vinh

- Tran Thi Hong

- Catherine Quillet

- Nham Thi Tuyet Thanh

- Roselyne Vallo

- Bach Thi Nhu Quynh

- Jean Pierre Moles

- Khuat Thi Hai Oanh

- Duong Thi Huong

- Delphine Rapoud

- Jonathan Feelemyer

- Laurent Michel

- Peter Vickerman

- Hannah Fraser

- Laurence Weiss

- Maud Lemoine

- Karine Lacombe

- Don Des Jarlais

- Pham Minh Khue

- Nicolas Nagot

7. Comment on ‘Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study’

- Seyed M. Alavian

- Heidar Sharafi

8. Efficacy and safety of anti-Hepatitis C virus regimens containing daclatasvir: a systematic review and meta-analysis from Egypt

- Muhammad Abdel-Gawad

- Amro M. Hassan

- Ahmed Q. Mohammed

- Ashraf M. Al Kabeer

- Eman Marwan

- Mohamed M. Abd Elnaser

- Mohamed El-Kassas

9. Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis

- Mohammad Saeid Rezaee-Zavareh

- Khashayar Hesamizadeh

- Bita Behnava

- Seyed Moayed Alavian

- Mohammad Gholami-Fesharaki

- Heidar Sharafi

10. Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C−infected patients with thalassemia

- Arezoo Khosravi

- Hamidreza Karimi‐Sari

- Mahdi Abedi‐Andani

- Bita Behnava

- Ali Namvar

- Ali Anvar

- Seyed Moayed Alavian

11. Letter: the efficacy of interferon‐free regimens in HCV‐related Child C cirrhosis needs careful interpretation

- M. S. Rezaee‐Zavareh

- S. M. Alavian

12. Update on Recommendations for the Clinical Management of Hepatitis C in Iran 2017

- Seyed Moayed Alavian

- Heidar Sharafi

13. The Efficacy of 12 Weeks of Sofosbuvir, Daclatasvir, and Ribavirin in Treating Hepatitis C Patients with Cirrhosis, Genotypes 1 and 3

- Shahin Merat

- Amir Houshang Sharifi

- Arghavan Haj-Sheykholeslami

- Hossein Poustchi

- Babak Fattahi

- Alireza Nateghi-Baygi

- Seyed Moayed Alavian

- Reza Malekzadeh

14. Highly sensitive and selective β-Ni(OH)2@CNTs modified electrode for detection of Anti-Hepatitis C

- Melad Lotfallah Adolf

- Mahmoud A. Hefnawy

- Shymaa S. Medany

- Eman Yossri Frag